Aminopyridine compound as aldehyde trapping agent
Summary
USPTO granted Patent US12595259B2 to Zhuhai United Laboratories Co., Ltd. for an aminopyridine compound functioning as an aldehyde trapping agent, including formula (I) and its pharmaceutically acceptable salts. The patent covers 18 claims and has applications in ophthalmic therapeutics.
What changed
USPTO issued Patent US12595259B2 granting Zhuhai United Laboratories Co., Ltd. exclusive rights to an aminopyridine compound for aldehyde trapping applications. The patent contains 18 claims covering the compound of formula (I), its salts, and pharmaceutical compositions. Filing date was June 17, 2021, with the patent now formally granted.
For pharmaceutical companies and drug manufacturers, this patent establishes IP protection for a specific aminopyridine-based aldehyde trapping agent with ophthalmic applications (A61P 27/00, A61P 27/04). Parties developing competing aldehyde trapping agents or ophthalmic therapeutics should assess freedom-to-operate implications to avoid infringement on the granted claims.
What to do next
- Monitor for updates
Archived snapshot
Apr 7, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Aminopyridine compound
Grant US12595259B2 Kind: B2 Apr 07, 2026
Assignee
ZHUHAI UNITED LABORATORIES CO., LTD.
Inventors
Peng Li, Chong Su, Xiaolin Li, Zhi Luo, Haiying He, Guoping Hu, Jian Li, Shuhui Chen
Abstract
An aminopyridine compound that may be used as an aldehyde trapping agent, and specifically disclosed is a compound represented by formula (I) and a pharmaceutically acceptable salt thereof.
CPC Classifications
C07D 213/74 C07D 401/04 C07D 401/06 C07D 401/12 C07D 407/04 C07D 409/04 C07D 413/04 C07D 417/04 A61K 31/443 A61K 31/4436 A61K 31/4439 A61K 31/444 A61K 31/4418 A61K 31/4412 A61P 27/00 A61P 27/04
Filing Date
2021-06-17
Application No.
18000684
Claims
18
Related changes
Get daily alerts for USPTO Patent Grants - Therapeutics (A61P)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Grants - Therapeutics (A61P) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.